Market Research Logo

Global Markets for Allergy Diagnostics and Treatment

Global Markets for Allergy Diagnostics and Treatment

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Report Includes
An overview of the global markets for allergy diagnostics and treatments.
Analyses of global market trends, with data from 2015 and 2016, and projections of CAGRs through 2021.
Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
Profiles of major players in the allergy diagnostics and treatments industry.

Report Scope
This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).

The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market. The report organizes information from diverse sources into a cohesive unit that includes:

A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.


Chapter 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Chapter 2: Summary and Highlights
Allergy Types
Projected Global Market
Global Allergy Diagnostic Market
Global Immunotherapy Market
Global Allergy Medication Market
Regional Diagnostic, Immunotherapy and Treatment Market Leaders
Diagnostic Market
Immunotherapy Market
Treatment Market
Chapter 3: Overview of Allergies
Definition of Allergies
Allergies and Asthma
Allergies and Climate Change
Types of Allergic Reactions
Environmental Allergies
Food Allergies
Latex Allergies
Insect Allergies
Diagnosis and Treatment
Skin Allergies
Atopic Eczema
Urticaria
Angioedema
Eye Allergies
Allergic Conjunctivitis
Allergies to Drugs and Biological Agents
Allergy Testing Manufacturers
Immunotherapy Products and Manufacturers
Allergy Medication Manufacturers
Topical Steroid Treatments
Anaphylaxis Treatments
Allergic Conjunctivitis Treatments
Generic Allergy Treatments
Mergers and Acquisitions in the Allergy Market
Chapter 4: Global Allergy Diagnostics Market
Projected Market for Allergy Diagnostic Products
Types of Diagnostic Tests
Skin Testing
Provocation Testing
Blood Analysis
Regional Marketplaces
Projected Americas Market for Allergy Diagnostics
Americas Allergy Diagnostic Market by Region
U.S.
Canada
Central and South America
Projected EMRA Market for Allergy Diagnostics
EMRA Allergy Diagnostic Market by Region
Europe
Middle East
Africa
Projected EMRA Allergy Diagnostic Market
Projected Asian Market for Allergy Diagnostics
Asian Allergy Diagnostic Market by Country
Allergic Triggers in Asian Region
Japan
China
India
Projected Asian Allergy Diagnostic Market
Chapter 5: Global Immunotherapy Market
SLIT Administration Approach
Immunologic Changes Following SLIT
Comparison of Subcutaneous Immunotherapy and Sublingual Immunotherapy
Single Antigen Versus Multi-Antigen Therapy
Immunotherapy Products
Immunotherapy Market Participants
Regional Markets
Americas
U.S.
Brazil
EMRA
Western Europe
Middle East
Asia
Japan
China
Chapter 6: Global Allergy Treatment Market
Global Market for Allergy Products
Prescription Allergy Products
Generic Allergy Products
Market Drivers
Generic Industry in the U.S.
OTC Allergy Products
Types of Allergy Medications
Antihistamines and Antihistamine Combinations
Benefits/Disadvantages
Antihistamine Products
Market Size for Antihistamines and Antihistamine Combinations
Sympathomimetics, Decongestants and Combinations
Overview
Benefits/Disadvantages
Sympathomimetics, Decongestants and Combinations Market Size
Corticosteroid Allergy Products
Overview
Benefits/Disadvantages
Corticosteroid Market Size
Mast Cell Stabilizers
Overview
Leukotriene Receptors
Anaphylaxis Treatment
Regional Markets for Allergy Treatments
Treatment Costs
Allergic Reactions
Allergy Population in the U.S.
Regional Variations
Sensitization by Gender
Sensitization by Age
Allergy Rates by Region
Americas Allergy Treatment Market
Americas Allergy Treatment Products by Region/Country
South and Central American Treatment Market
Allergies in Europe
Projected EMRA Market for Prescription, Generic and OTC Allergy Products
Allergy Treatment in Russia
Allergy Treatment in Asia
Japan
China
India
Australia/New Zealand
Chapter 7: Developments in Allergy Testing and Treatment, and Recent Patents
New Developments in Diagnostic Testing
Allergen Component-resolved Diagnostics
Advances in Treatments
Chinese Herbal Medicine
Immunotherapy
Anergis
B-cell Epitope-based Immunotherapy
Nasal Filters
Allergy Therapeutics
Epicutaneous Immunotherapy
Anti-interleukin-31 Receptor A Antibody for Atopic Dermatitis
Chapter 8: Company Profiles
About BCC Research
About BCC Research
BCC Membership
BCC Custom Research
List of Tables
Table 1 Summary Table: Global Allergy Diagnostic and Treatment Markets, by Type, Through 2021 ($
Millions)
Table 2 Most Common Food Allergies in the U.S. and Europe
Table 3 Food Allergens (in Order of Decreasing Prevalence) in Various Countries
Table 4 Tests for Food Allergies
Table 5 Potential Triggers for Hives
Table 6 Allergy Testing Manufacturers by Company and Location
Table 7 Allergy Immunotherapy Manufacturers by Company and Type of Product
Table 8 Allergy Medication Manufacturers by Company, Product Name, Type, Formulation and
Indication for Use of Product
Table 9 Topical Steroid Medication Manufacturers by Potency, Company, Product Name and
Formulation
Table 10 Anaphylaxis Medication Manufacturers by Company, Product Name, Type, Formulation and
Indication for Use of Product
Table 11 Allergic Conjunctivitis Medication Manufacturers by Company, Product Name Type and
Formulation
Table 12 Generic Allergy Medication Manufacturers by Type, Product Name, Formulation and Indication
Table 13 Selected Mergers and Acquisitions Pertinent to the Allergy Diagnostic and Treatment Market,
2009–2017
Table 14 Global Market for Allergy Diagnostic Products by Type, Through 2021 ($ Millions)
Table 15 Global Appropriate Testing for Allergies, by Type of Allergy and Test
Table 16 Global Market for Allergy Diagnostic Products, by Region, Through 2021 ($ Millions)
Table 17 Americas Market for Allergy Diagnostic Products by Type of Test, Through 2021 ($ Millions).. 41
Table 18 Americas Market for Allergy Diagnostic Products by Region/Country, Through 2021 ($
Millions)
Table 19 EMRA Market for Allergy Diagnostic Products, by Type of Test, Through 2021 ($ Millions)
Table 20 EMRA Market for Allergy Diagnostic Products by Region/Country, Through 2021 ($ Millions) 49
Table 21 Asian Market for Allergy Diagnostic Products, by Type of Test, Through 2021 ($ Millions)
Table 22 Comparative Population Prevalence of Diagnosed Nasal Allergies (%)
Table 23 Asian Market for Allergy Diagnostic Products, by Region/Country, Through 2021 ($ Millions) 55
Table 24 Global Market for Immunotherapy Allergy Products by Form of Administration, Through 2021
($ Millions)
Table 25 Allergen Sublingual and Injectable Allergen Extract Immunotherapy Treatments, by Type
Table 26 Global Market for Immunotherapy Products, by Region, Through 2021 ($ Millions)
Table 27 Americas Market for Immunotherapy Products, by Region/Country, Through 2021 ($ Millions)
Table 28 EMRA Market for Immunotherapy Products, by Region/Country, Through 2021 ($ Millions).. 69
Table 29 Asia Market for Immunotherapy Products, by Region/Country, Through 2021 ($ Millions)
Table 30 Global Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 31 Global Market for Prescription Allergy Treatment Products, by Form of Administration,
Through 2021 ($ Millions)
Table 32 Global Market for Generic Allergy Treatment Products, by Form of Administration, Through
2021 ($ Millions)
Table 33 Global Market for OTC Allergy Treatment Products, by Form of Administration, Through 2021
($ Millions)
Table 34 Global Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 35 Antihistamine and Antihistamine Combination Products, 2017
Table 36 Global Market for Antihistamine and Antihistamine Combinations, by Form of Administration,
Through 2021 ($ Millions)
Table 37 Available Sympathomimetics, Decongestants and Combinations, by Name and Manufacturer,
2017
Table 38 Global Market for Sympathomimetics, Decongestants and Combinations by Form of
Administration, Through 2021 ($ Millions)
Table 39 Corticosteroid Preparations, by Name and Manufacturer
Table 40 Global Market for Allergy Corticosteroids, by Form of Administration, Through 2021 ($
Millions)
Table 41 Global Market for Allergy Mast Cell Stabilizers, by Form of Administration, Through 2021 ($
Millions)
Table 42 Global Market for Leukotriene Receptor Treatment Products, Through 2021 ($ Millions)
Table 43 Global Market for Allergy Treatment Products, by Region, Through 2021 ($ Millions)
Table 44 Estimated Costs for Treating Allergies in the U.S., 2012 ($ Billions)
Table 45 Worst U.S. Cities for Fall Allergies, 2016
Table 46 Americas Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 47 Americas Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 48 Americas Market for Allergy Treatment Products, by Region/Country, Through 2021 ($
Millions)
Table 49 Features of Food Allergy in Latin America
Table 50 EMRA Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 51 EMRA Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 52 EMRA Market for Allergy Treatment Products, by Region/Country, Through 2021 ($ Millions)
Table 53 Asia Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
Table 54 Medications for Allergy Treatment in India, by Name, Type and Condition, 2016
Table 55 Asian Market for Allergy Treatment Products, by Region/Country, Through 2021 ($ Millions) 114
Table 56 Alere’s Product Portfolio
Table 57 Alere’s Recent Developments, 2015-February 2017
Table 58 Allergan’s Product Portfolio
Table 59 Allergan’s Recent Developments, 2015-February 2017
Table 60 Alcon Laboratories’ Product Portfolio
Table 61 ALK-Abelló’s Product Portfolio
Table 62 ALK-Abelló’s Recent Developments, 2015-February 2017
Table 63 Allergy Laboratories’ Product Portfolio
Table 64 Allergopharma AG’s Product Portfolio
Table 65 Amedra’s Product Portfolio
Table 66 Amedra’s Recent Developments, 2015-February 2017
Table 67 Ani Biotech Oy’s Product Portfolio
Table 68 Aqua Pharmaceuticals’ Product Portfolio
Table 69 Aqua Pharmaceuticals’ Recent Development, 2015-February 2017
Table 70 Beckman Coulter’s Product Portfolio
Table 71 Beckman Coulter’s Recent Developments, 2015-February 2017
Table 72 Biomerica Inc.’s Product Portfolio
Table 73 Cortez Diagnostics’ Product Portfolio
Table 74 Ferndale’s Product Portfolio
Table 75 First Diagnostic’s Product Portfolio
Table 76 Gladerma’s Product Portfolio
Table 77 Gladerma’s Recent Developments, 2015-February 2017
Table 78 GlaxoSmithKline’s Product Portfolio
Table 79 GlaxoSmithKline’s Recent Developments, 2015-February 2017
Table 80 Greer’s Human Allergy Product Portfolio
Table 81 HAL Allergy Group’s Product Portfolio
Table 82 HAL Allergy Group’s Recent Developments, 2015-February 2017
Table 83 Hitachi Chemical Diagnostics’ Product Portfolio
Table 84 Hitachi Chemical Diagnostics’ Recent Developments, 2015-February 2017
Table 85 Hycor Biomedical’s Product Portfolio
Table 86 Hycor Biomedical’s Recent Developments, 2015-February 2017
Table 87 Johnson & Johnson’s Product Portfolio
Table 88 Johnson & Johnson’s Recent Development, 2015-February 2017
Table 89 Jubilant HollisterStier’s Product Portfolio
Table 90 Kyowa Hakko Kirin’s Product Portfolio
Table 91 Kyowa Hakko Kirin’s Recent Development, 2015-February 2017
Table 92 LabCorp’s Product Portfolio
Table 93 LabCorp’s Recent Acquisitions, 2015-February 2017
Table 94 Lincoln Diagnostics’ Product Portfolio
Table 95 Lupin’s Product Portfolio
Table 96 Lupin’s Recent Developments, 2015-February 2017
Table 97 Meda’s Product Portfolio
Table 98 Meda’s Recent Development, 2015-February 2017
Table 99 Merck’s Product Portfolio
Table 100 Merck’s Recent Developments, 2015-February 2017
Table 101 Mylan’s Product Portfolio
Table 102 Mylan’s Recent Developments, 2015-February 2017
Table 103 Pfizer’s Product Portfolio
Table 104 Pfizer’s Recent Developments, 2015-February 2017
Table 105 Pierre Fabre’s Product Portfolio
Table 106 Pierre Fabre’s Recent Developments, 2015-February 2017
Table 107 Quest Diagnostics’ Product Portfolio
Table 108 Quest Diagnostics’ Recent Developments, 2015-February 2017
Table 109 Ranbaxy Product Portfolio
Table 110 Roche’s Product Portfolio
Table 111 Roche’s Recent Developments, 2015-February 2017
Table 112 Sandoz’s Product Portfolio
Table 113 Sandoz’s Recent Developments, 2015-February 2017
Table 114 Sanofi’s Product Portfolio
Table 115 Sanofi’s Recent Developments, 2015-February 2017
Table 116 Siemens Healthcare’s Product Portfolio
Table 117 Siemens Healthcare’s Recent Developments, 2015-February 2017
Table 118 SmartPractice Denmark’s Product Portfolio
Table 119 Terumo Medical’s Products Portfolio
Table 120 Terumo Medical’s Recent Developments, 2015-February 2017
Table 121 Thermo Fisher Diagnostics’ Product Portfolio
Table 122 Thermo Fisher Diagnostics’ Recent Developments, 2015-February 2017
Table 123 UCB’s Product Portfolio
Table 124 UCB’s Recent Development, 2015-February 2017
List of Figures
Figure 1 Summary Figure: Global Allergy Diagnostic and Treatment Market, by Region, 2016 and 2021
(%)
Figure 2 Allergy Diagnostic Manufacturer Market by Country, 2014 (%)
Figure 3 Global Market for Allergy Diagnostic Testing Products by Type, 2016 and 2021 (%)
Figure 4 Global Market for Allergy Diagnostic Products, by Region, 2016 and 2021 (%)
Figure 5 Americas Market for Allergy Diagnostic Products by Type of Test, 2016 and 2021 (%)
Figure 6 Americas Market for Allergy Diagnostic Products by Region/Country, 2016 and 2021 (%)
Figure 7 EMRA Market for Allergy Diagnostic Products by Type of Test, 2016 and 2021 (%)
Figure 8 EMRA Market for Allergy Diagnostic Products by Region/Country, 2016 and 2021 (%)
Figure 9 Asian Market for Allergy Diagnostic Products by Type of Test, 2016 and 2021 (%)
Figure 10 Diagnosis for Allergic Rhinitis in China, 2011 (%)
Figure 11 Asian Market for Allergy Diagnostic Products, by Region/Country, 2016 and 2021 (%)
Figure 12 Global Market for Immunotherapy Allergy Products by Form of Administration, 2016 and 2021
(%)
Figure 13 Market Analysis for Immunotherapy Products by Participant, 2014 (%)
Figure 14 Global Market for Immunotherapy Products, by Region, 2016 and 2021 (%)
Figure 15 Americas Market for Immunotherapy Products, by Region/Country, 2016 and 2021 (%)
Figure 16 EMRA Market for Immunotherapy Products, by Region/Country, 2016 and 2021 (%)
Figure 17 Asia Market for Immunotherapy Products, by Region/Country, 2016 and 2021 (%)
Figure 18 Global Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
Figure 19 Global Market for Generic Allergy Treatment Products, by Form of Administration, 2016 and
2021 (%)
Figure 20 Global Market for OTC Allergy Treatment Products, by Form of Administration, 2016 and 2021
(%)
Figure 21 Global Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
Figure 22 Global Market for Antihistamine and Antihistamine Combinations, by Form of Administration,
2016 and 2021 (%)
Figure 23 Global Market for Allergy Treatment Products, by Region, 2016 and 2021 (%)
Figure 24 Allergy Demographics, by Type or Cause, 2012 (%)
Figure 25 Percentage of U.S. Population With and Without Allergies, 2016 and 2021 (%)
Figure 26 Regions/Countries Within the Americas With Highest Concentrations of Diagnosed Allergy
Cases, 2013 (%)
Figure 27 Americas Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
Figure 28 EMRA Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
Figure 29 Asia Market for Allergy Treatment Products, by Region/Country, 2016 and 2021 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report